Still Need To Complete CME Credits For 2022 Exam? Look At These Options!
Find links to online CME options so that you an still apply to take the November 2022 exam by the final application deadline of August 8.
Announcing New Exam Development and Delivery Partnership; Updated 2022 Exam Window Dates
The American Board of Obesity Medicine (ABOM) announced today it is partnering with Professional Testing, Inc to develop and administer the annual certification examination for obesity medicine physicians through Pearson VUE, the global leader in exam delivery for medical organizations.
Inge And Wadden Earn ABOM’s Top Honor as 2021 Distinguished Leaders
Learn about the accomplishments of the two doctors who have earned the prestigious Distinguished Leader in Obesity Medicine Award for 2021.
Introducing ABOM Medical Director Kimberly A. Gudzune, MD, MPH
Dr. Kimberly Gudzune is ABOM’s new medical director.
More Than 1,400 Apply For 2021 ABOM Certification Exam
The COVID-19 pandemic did not keep doctors from seeking certification in obesity medicine. A record 1,400+ physicians applied to take the 2021 American Board of Obesity Medicine (ABOM) certification exam, which tests doctors for their competency in treating obesity. Physician candidates will take the test between February 18-25 at computer-based testing centers throughout the United States and Canada and through live remote proctoring. The total number of applicants (1,407) represents a 40 percent increase from the previous class of applicants. Over the past two years, more than 2,400 doctors have applied for ABOM certification.
ABOM Diplomates Offer Evidence-Based Care to Patients With Obesity, New Study Finds
In examining three evidence-based obesity management guidelines – AHA/ACC/TOS, AACE/ACE and OMA, the study found that the majority of physicians had moderate or high adherence to recommendations in these guidelines. The study determined concordance by matching treatment services offered by the physicians with services recommended by each organization. Guideline-recommended treatments have been associated with clinically significant weight loss in clinical trials.